Exact Mass: 304.9994

Exact Mass Matches: 304.9994

Found 42 metabolites which its exact mass value is equals to given mass value 304.9994, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Isoimide

N-(Bromophenyl)-3,4,5,6-tetrahydroisophthalimide

C14H12BrNO2 (305.0051)

Imide

N-(4-Bromophenyl)-3,4,5,6-tetrahydrophthalimide

C14H12BrNO2 (305.0051)

ethyl 2-(4-iodoanilino)acetate

ethyl 2-(4-iodoanilino)acetate

C10H12INO2 (304.9913)

MCULE-6331155634

MCULE-6331155634

C11H7ClF3N3S (305.0001)

5-Chloro-2-methyl-3-(3-sulfopropyl)benzothiazolium,inner salt

5-Chloro-2-methyl-3-(3-sulfopropyl)benzothiazolium,inner salt

C11H12ClNO3S2 (304.9947)

4-Bromo-2-methoxy-N-phenylbenzamide

4-Bromo-2-methoxy-N-phenylbenzamide

C14H12BrNO2 (305.0051)

3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide

3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

5-Bromo-2-deoxycytidine

5-Bromo-2-deoxycytidine

C9H12BrN3O4 (305.0011)

BENZYL 4-BROMOPHENYLCARBAMATE

BENZYL 4-BROMOPHENYLCARBAMATE

C14H12BrNO2 (305.0051)

ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE

ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE

C9H12BrN3O4 (305.0011)

N-CHLOROACETYL-3,5-BIS(TRIFLUOROMETHYL)ANILINE

N-CHLOROACETYL-3,5-BIS(TRIFLUOROMETHYL)ANILINE

C10H6ClF6NO (305.0042)

n-t-butyl 3-bromo-4-methylbenzenesulfonamide

n-t-butyl 3-bromo-4-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

N-(4-bromophenyl)-4-methoxy-benzamide

N-(4-bromophenyl)-4-methoxy-benzamide

C14H12BrNO2 (305.0051)

6-bromo-3-chloro-N-(oxan-4-ylmethyl)pyrazin-2-amine

6-bromo-3-chloro-N-(oxan-4-ylmethyl)pyrazin-2-amine

C10H13BrClN3O (304.993)

7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID

7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID

C14H12BrNO2 (305.0051)

2-Bromo-N-pentylbenzenesulfonamide

2-Bromo-N-pentylbenzenesulfonamide

C11H16BrNO2S (305.0085)

4-BROMO-3-METHOXY-N-PHENYLBENZAMIDE

4-BROMO-3-METHOXY-N-PHENYLBENZAMIDE

C14H12BrNO2 (305.0051)

ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE

ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE

C10H9Cl2N3O4 (304.997)

3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester

3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester

C14H12BrNO2 (305.0051)

[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

C11H16BrNO2S (305.0085)

3-(2-Amino-4-pyrimidinyl)-6-bromo-1H-pyrrolo[2,3-b]pyridin-4-ol

3-(2-Amino-4-pyrimidinyl)-6-bromo-1H-pyrrolo[2,3-b]pyridin-4-ol

C11H8BrN5O (304.9912)

Methyl 2-(2-aminoethyl)-5-iodobenzoate

Methyl 2-(2-aminoethyl)-5-iodobenzoate

C10H12INO2 (304.9913)

Methyl 2-[(1S)-1-aminoethyl]-5-iodobenzoate

Methyl 2-[(1S)-1-aminoethyl]-5-iodobenzoate

C10H12INO2 (304.9913)

Benzyl 2-amino-5-bromobenzoate

Benzyl 2-amino-5-bromobenzoate

C14H12BrNO2 (305.0051)

methyl 4-(dimethylamino)-3-iodobenzoate

methyl 4-(dimethylamino)-3-iodobenzoate

C10H12INO2 (304.9913)

BENZYL (2-IODOETHYL)CARBAMATE

BENZYL (2-IODOETHYL)CARBAMATE

C10H12INO2 (304.9913)

5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide

5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

2-(4-Chloro-3-nitrobenzoyl)benzoic acid

2-(4-Chloro-3-nitrobenzoyl)benzoic acid

C14H8ClNO5 (305.0091)

3-Bromo-N-butyl-5-methylbenzenesulfonamide

3-Bromo-N-butyl-5-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide

3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide

4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

methyl 2-amino-4-ethyl-5-iodobenzoate

methyl 2-amino-4-ethyl-5-iodobenzoate

C10H12INO2 (304.9913)

Apoptosis Activator 2

Apoptosis Activator 2

C15H9Cl2NO2 (305.001)

3-bromo-N,N-diethyl-4-methylbenzenesulfonamide

3-bromo-N,N-diethyl-4-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide

3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide

4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE

N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE

C11H16BrNO2S (305.0085)

3-Bromo-N-pentylbenzenesulfonamide

3-Bromo-N-pentylbenzenesulfonamide

C11H16BrNO2S (305.0085)

7-Nitro-9-oxo-9H-fluorene-2-sulfonic acid

7-Nitro-9-oxo-9H-fluorene-2-sulfonic acid

C13H7NO6S (304.9994)

3-Iodo-4-(propylamino)benzoic acid

3-Iodo-4-(propylamino)benzoic acid

C10H12INO2 (304.9913)

2-bromo-N-(3-methoxyphenyl)benzamide

2-bromo-N-(3-methoxyphenyl)benzamide

C14H12BrNO2 (305.0051)

Taminadenant

Taminadenant

C10H8BrN7 (305.0025)

Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].